<DOC>
	<DOCNO>NCT00489996</DOCNO>
	<brief_summary>The purpose study evaluate response rate 3 week versus 4 week treatment gemcitabine cisplatin first line treatment non-small cell lung cancer patient China .</brief_summary>
	<brief_title>Trial Comparing 3 4 Week Regimen Gemcitabine Cisplatin Patients With Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histologic cytologic diagnosis NSCLC Presence Stage IIIB Stage IV disease Patients must receive prior systemic chemotherapy Patients must least one bidimensionally measurable lesion clearly define margin two perpendicular diameter clearly measurable following : chest xray , least one diameter 1.0 cm great , CT , diameter great distance cut image study , palpation , diameter 2.0 cm great , disease progress area prior radiation therapy may include No prior radiotherapy target organ , radiotherapy least 2 week prior study enrollment patient must fully recover acute toxic effect treatment . Are investigator site personnel directly affiliate study , immediate family investigator site personnel directly affiliate study . Immediate family define spouse , parent , child , sibling , whether biological legally adopt . Are employ Lilly ( , employee , temporary contract worker , designees responsible conduct study ) . Immediate family Lilly employee may participate Lilly sponsored clinical trial , permit participate Lilly facility . Immediate family define spouse , parent , child , sibling , whether biological legally adopt . Have receive treatment within last 30 day drug receive regulatory approval indication time study entry . Have previously complete withdrawn study study investigate gemcitabine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>